318 related articles for article (PubMed ID: 17724303)
1. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
Amato MP; De Stefano N
Neurology; 2007 Aug; 69(9):938; author reply 938-9. PubMed ID: 17724303
[No Abstract] [Full Text] [Related]
2. Benign or not benign MS: a role for routine neuropsychological assessment?
Benedict RH; Fazekas F
Neurology; 2009 Aug; 73(7):494-5. PubMed ID: 19641172
[No Abstract] [Full Text] [Related]
3. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
5. Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients.
Minneboo A; Uitdehaag BM; Ader HJ; Barkhof F; Polman CH; Castelijns JA
Neurology; 2005 Jul; 65(1):56-61. PubMed ID: 16009885
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis.
Gold SM; Raji A; Huitinga I; Wiedemann K; Schulz KH; Heesen C
J Neuroimmunol; 2005 Aug; 165(1-2):186-91. PubMed ID: 15935481
[TBL] [Abstract][Full Text] [Related]
7. The natural history of multiple sclerosis.
Deshpande R; Kremenchutzky M; Rice GP
Adv Neurol; 2006; 98():1-15. PubMed ID: 16400823
[No Abstract] [Full Text] [Related]
8. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
[TBL] [Abstract][Full Text] [Related]
9. The role of MRS and fMRI in multiple sclerosis.
Tartaglia MC; Arnold DL
Adv Neurol; 2006; 98():185-202. PubMed ID: 16400835
[TBL] [Abstract][Full Text] [Related]
10. The use of modern magnetic resonance techniques to monitor disease evolution in multiple sclerosis.
Filippi M; Rocca MA
Adv Neurol; 2006; 98():167-83. PubMed ID: 16400834
[No Abstract] [Full Text] [Related]
11. The incomplete nature of multiple sclerosis relapse resolution.
Lublin FD
J Neurol Sci; 2007 May; 256 Suppl 1():S14-8. PubMed ID: 17337274
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment in multiple sclerosis: a longitudinal study.
Amato MP; Ponziani G; Amaducci L
Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():465-8. PubMed ID: 10689495
[No Abstract] [Full Text] [Related]
13. [Clinical features of relapsing remitting-multiple sclerosis. Prognostic factors].
Fernández-Fernández O
Rev Neurol; 2002 Dec 1-15; 35(11):1067-73. PubMed ID: 12497314
[TBL] [Abstract][Full Text] [Related]
14. Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis.
Benedict R
Mult Scler; 2009 Jul; 15(7):777-8. PubMed ID: 19542261
[No Abstract] [Full Text] [Related]
15. Pediatric multiple sclerosis.
Bigi S; Banwell B
J Child Neurol; 2012 Nov; 27(11):1378-83. PubMed ID: 22914372
[TBL] [Abstract][Full Text] [Related]
16. Making the diagnosis of multiple sclerosis.
Birnbaum G
Adv Neurol; 2006; 98():111-24. PubMed ID: 16400830
[No Abstract] [Full Text] [Related]
17. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X
Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658
[TBL] [Abstract][Full Text] [Related]
18. A composite score to predict short-term disease activity in patients with relapsing-remitting MS.
Sormani MP; Rovaris M; Comi G; Filippi M
Neurology; 2007 Sep; 69(12):1230-5. PubMed ID: 17875911
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis.
Hawker K; Frohman E
Prim Care; 2004 Mar; 31(1):201-26. PubMed ID: 15110166
[No Abstract] [Full Text] [Related]
20. MRI as an outcome in multiple sclerosis clinical trials.
Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
